Knockdown of LncRNA-XIST inhibited non-small-cell lung cancer (NSCLC) progression by triggering pyroptosis via the miR-335/SOD2/ROS signaling pathway (Liu et al., 2019). Here, XIST is linked to non-small cell lung carcinoma.